Michael Reed, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Hershey, PANPI 1447228069
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.8%), education and travel and lodging — rather than concentrated in one kind of arrangement. Gyrus ACMI, Inc. accounts for 64.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $16,449 and has fallen 57.3% since, to $7,025 in 2025.
Across 51 payments — averaging $595.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gyrus ACMI, Inc.$20K
- Intuitive Surgical$7K
- Olympus America Inc.$2K
- Medical Device Business Services, Inc.$1K
- Johnson & Johnson$163
- Medtronic$103
- plus $205 from 3 others
Across 33 payments — averaging $2026.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gyrus ACMI, Inc.$54K
- Spiration, Inc.$13K
What the payments were for
- Consulting fees$18,14360%
- Speaking & faculty fees$1,8456%
- Travel & lodging$4,49115%
- Food & beverage$8693%
- Education$5,00016%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gyrus ACMI, Inc. | 23 | $19,677 |
| Intuitive Surgical | 15 | $6,965 |
| Olympus America Inc. | 1 | $1,845 |
| Medical Device Business Services, Inc. | 4 | $1,388 |
| Johnson & Johnson | 2 | $163 |
| Medtronic | 1 | $103 |
| Caris MPI, Inc. | 1 | $91 |
| Atricure, Inc. | 2 | $76 |
| Pulmonx Corporation | 2 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,257
- Spiration Valve System$3,690
- DA VINCI SP$2,500
- NA$1,344
- Monarch Platform$114
- COREVALVE EVOLUT R$103
How this compares
$30,348 in reported general payments places this provider in the 85th percentile of 314 thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 49 | $529 |
| ClopidogrelClopidogrel Bisulfate | 16 | $86 |
| Tamsulosin Hcl | 32 | $49 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Hershey
- Abdulrhman ElnaggarHershey$40K
- Balakrishnan MaheshHershey$30K
- Behzad SoleimaniHershey$24K
- Joseph BavariaAllentown$1.7M
- Basel RamlawiWynnewood$1.1M
- Patrick RossWynnewood$956K
- Mark AndersonPhiladelphia$527K
- Scott GoldmanWynnewood$354K
- Frank BowenCamp Hill$310K
- Michael AckerPhiladelphia$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.